BioSpace News Archive

Riverchase Dermatology and Cosmetic Surgery is pleased to announce the newest member of their team, Coty Benmaman M.D., FAAD. Dr. Benmaman is currently accepting new patients at the Downtown Naples office, located at 261 9th St South, Naples, FL 34102.

Famela Ramos announced today the Endorsement of Dr. Peter Farrell, the founder and Chairman of ResMed, the San Diego based global manufacturer of CPAP masks, machines and other products that diagnose, treat or help manage sleep-disordered breathing.

GENIFER M (www.geniferm.com), the nation’s first line of luxury cannabis-inspired jewelry, announced it will donate a portion of proceeds of all sales from its Healing Collection to breast cancer charities during the month of October.

EDDA Technology, a global leading provider in advanced imaging-guided precision treatment solutions, announced today that the company has completed the installation of IQQA®- Liver MultiModality at Mayo Clinic in Jacksonville, Florida.

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that data from its OASIS Phase 2 clinical study for its investigational drug candidate etrasimod, a next-generation, oral, S1P receptor modulator with optimized activity being evaluated in ulcerative colitis (UC), were presented by Dr. William J. Sandborn at the American College of Gastroenterology Annual Meeting.

Veracyte, Inc. (Nasdaq: VCYT) announced the presentation of data demonstrating that the Envisia Genomic Classifier can help physicians more confidently diagnose interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), without the need for surgery.

Devoted Health today announced approval from the Centers for Medicare and Medicaid Services to offer Medicare Advantage Plans in the state of Florida. The healthcare company is building a new provider network with some of the most trusted doctors and hospitals in Central and South Florida.

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has commenced the U.S. pivotal trial that will study its self-expanding CENTERA transcatheter valve for severe, symptomatic aortic stenosis (AS) patients at intermediate risk of open-heart surgery.

Catalent, Inc. (NYSE: CTLT) (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, today announced that it will release financial results for the first quarter of fiscal year 2019 ended September 30, 2018, before the market open on Tuesday, November 6, 2018.

Mohamed B. Jah, MD, ACP, MBA, ADBA, Hon. DL of Choctaw, Mississippi has been recognized as a Top Doctor and honored on the famous Reuters Billboard in Times Square in New York City by Strathmore’s Who’s Who Worldwide for his outstanding contributions and achievements for almost 25 years in the field of healthcare.